Biongevity, the pioneering longevity clinic in Dubai, commenced operations on Friday, September 13, 2024, marking a significant advancement in the UAE’s healthcare landscape. The clinic is dedicated to precision medicine, offering individualized healthcare solutions through advanced genomics, AI-powered insights, and data analytics to enhance health-span and life quality. The much-anticipated launch event drew key figures in healthcare, technology, and wellness sectors.
During the event, Dr. Anmol S. Kapoor, MD FRCPC, Cardiologist and Founder of Biongevity, emphasized the clinic’s transformative mission. “We are excited to bring Biongevity to Dubai, a city leading in technological and healthcare innovations. Our objective is to transcend disease management and emphasize preventive care by providing personalized healthcare solutions tailored to each individual’s genetic makeup, lifestyle, and microbiome. This signifies a new chapter in health optimization.”
The demand for longevity and life-extension treatments is growing globally, driven by an increasing focus on health, wellness, and anti-aging solutions. As advancements in biotechnology and regenerative medicine continue, more people seek methods to prolong their healthy years and improve life quality.
The global market for longevity treatments is set to rise due to several key factors. The market for anti-aging products and services was valued at approximately US$60.42 billion in 2021 and is projected to nearly double to US$120.3 billion by 2030, with a compound annual growth rate (CAGR) of 7.2 percent. One major driver is the aging population, particularly in Europe, the U.S., and parts of Asia, where there is a growing interest in treatments to slow aging or alleviate age-related diseases. Additionally, advancements in biotechnology, such as gene therapy, stem cell research, and anti-aging drugs, are enabling interventions at the cellular level.
High net-worth individuals are also significantly contributing, as many are early adopters of these treatments, seeking to extend their lifespan and maintain youthful vitality. In regions like the U.S. and the Middle East, high-income individuals spend between US$15,000 and US$100,000 annually on longevity treatments, including personalized therapies and cutting-edge interventions. Moreover, the increasing trend towards holistic health and preventive care supports the integration of longevity medications as part of a comprehensive wellness strategy. Preventive healthcare also commands significant spending, with individuals paying between US$5,000 to US$10,000 annually for regular check-ups, diagnostics, and early interventions aimed at extending both life expectancy and quality of life. This rise in consumer spending underscores the growing emphasis on enhancing longevity and overall well-being.
The demand for these treatments is most apparent in wellness hubs like the UAE, where clinics like Biongevity are capitalizing on this trend by offering advanced treatments designed to increase longevity.
Biongevity is revolutionizing healthcare with a range of innovative services, including advanced genomic testing that generates personalized health plans based on a patient’s unique genetic profile. The clinic’s multidisciplinary team, comprising experts from various medical fields, works collaboratively to address all aspects of a patient’s health. The clinic provides a full suite of precision medical specialties such as general practice, internal medicine, cardiology, gastroenterology, and dermatology, all aimed at offering bespoke healthcare solutions. Through a blend of state-of-the-art diagnostics, genetic analyses, and AI-driven medical insights, Biongevity is poised to set a new standard in healthcare.
The clinic utilizes cutting-edge technologies, including PanomiQ and BioELR, to deliver comprehensive, data-driven health assessments and customized treatment strategies. By integrating advanced AI algorithms with multi-omics data analysis, Biongevity’s approach marks a significant leap in precision medicine and longevity science. Additionally, its Virtual Hypertension Clinic provides personalized care remotely. Complementing these services, the Longevity Plus Supplements offer science-backed nutrition to support long-term health and vitality.
Biongevity’s launch aligns with the UAE’s strategic goals of advancing genomics and preventive healthcare. The Emirati Genome Programme plays a pivotal role in this mission by exploring the genetic makeup of Emiratis through advanced DNA sequencing and AI technologies. This initiative aims to produce high-quality genomic data, forming the foundation for personalized and preventive healthcare in the UAE. The resulting reference genome will provide a thorough understanding of rare genetic disorders and pave the way for new treatments.
With over 600,000 DNA samples already collected, the Emirati Genome Programme is central to the nation’s efforts to position itself as a global leader in genomics. Dr. Kapoor emphasized Biongevity’s commitment to this vision: “Our clinic’s mission mirrors the UAE’s dedication to fostering innovation in healthcare, especially in genomics and longevity science. We aim to make Dubai a global hub for precision health, benefiting both local residents and international visitors seeking advanced healthcare solutions.”
Following its successful launch in Dubai, Biongevity has ambitious plans for international expansion, with clinics slated to open in major cities across the GCC, London, Silicon Valley, and Toronto by 2026. This expansion will further cement Biongevity’s vision of making advanced health technologies accessible globally.
Biongevity Clinic is a leading healthcare facility in Dubai, committed to advancing precision health and longevity medicine. The clinic integrates advanced genomic testing, artificial intelligence, and personalized healthcare strategies to shift the focus from disease management to health-span optimization. Biongevity offers a comprehensive range of services, including precision diagnostics in general practice, internal medicine, cardiology, dermatology, and more. By leveraging advanced technology and data-driven insights, Biongevity provides patients with personalized health solutions tailored to their unique genetic makeup and lifestyle. At the core of Biongevity’s services is the BioELR platform, an AI-powered electronic medical records system that delivers precise, individualized health insights. Additionally, the clinic features a Virtual Hypertension Clinic for remote care and Longevity Plus Supplements, designed to support long-term health through science-backed nutrition. Biongevity is dedicated to revolutionizing healthcare by making advanced precision medicine accessible to individuals across schools, gyms, resorts, and residential communities. As part of its global expansion strategy, Biongevity plans to establish clinics in major cities across the GCC, London, Silicon Valley, and Toronto by 2026. With a vision to democratize access to innovative healthcare solutions, Biongevity is positioned to play a key role in advancing the UAE’s leadership in genomics and longevity science, offering world-class care to both local residents and international patients.
